No abstract

The alarmingly high mortality rate and increasing global prevalence of cardiovascular diseases (CVDs) signify the crucial need for early detection schemes. Phonocardiogram (PCG) signals have been historically applied in this domain owing to its simplicity and cost-effectiveness. In this paper, we propose CardioXNet, a novel lightweight end-to-end CRNN architecture for automatic detection of five classes of cardiac auscultation namely normal, aortic stenosis, mitral stenosis, mitral regurgitation and mitral valve prolapse using raw PCG signal. The process has been automated by the involvement of two learning phases namely, representation learning and sequence residual learning. Three parallel CNN pathways have been implemented in the representation learning phase to learn the coarse and fine-grained features from the PCG and to explore the salient features from variable receptive fields involving 2D-CNN based squeeze-expansion. Thus, in the representation learning phase, the network extracts efficient timeinvariant features and converges with great rapidity. In the sequential residual learning phase, because of the bidirectional-LSTMs and the skip connection, the network can proficiently extract temporal features without performing any feature extraction on the signal. The obtained results demonstrate that the proposed end-toend architecture yields outstanding performance in all the evaluation metrics compared to the previous stateof-the-art methods with up to 99.60% accuracy, 99.56% precision, 99.52% recall and 99.68% F1-score on an average while being computationally comparable. This model outperforms any previous works using the same database by a considerable margin. Moreover, the proposed model was tested on PhysioNet/CinC 2016 challenge dataset achieving an accuracy of 86.57%. Finally the model was evaluated on a merged dataset of Github PCG dataset and PhysioNet dataset achieving excellent accuracy of 88.09%. The high accuracy metrics on both primary and secondary dataset combined with a significantly low number of parameters and end-to-end prediction approach makes the proposed network especially suitable for point of care CVD screening in low resource setups using memory constraint mobile devices.

Rapid and precise diagnosis of COVID-19 is one of the major challenges faced by the global community to control the spread of this overgrowing pandemic. In this paper, a hybrid neural network is proposed, named CovTANet, to provide an end-to-end clinical diagnostic tool for early diagnosis, lesion segmentation, and severity prediction of COVID-19 utilizing chest computer tomography (CT) scans. A multi-phase optimization strategy is introduced for solving the challenges of complicated diagnosis at a very early stage of infection, where an efficient lesion segmentation network is optimized initially which is later integrated into a joint optimization framework for the diagnosis and severity prediction tasks providing feature enhancement of the infected regions. Moreover, for overcoming the challenges with diffused, blurred, and varying shaped edges of COVID lesions with novel and diverse characteristics, a novel segmentation network is introduced, namely Tri-level Attention-based Segmentation Network (TA-SegNet). This network has significantly reduced semantic gaps in subsequent encoding decoding stages, with immense parallelization of multi-scale features for faster convergence providing considerable performance improvement over traditional networks. Furthermore, a novel tri-level attention mechanism has been introduced, which is repeatedly utilized over the network, combining channel, spatial, and pixel attention schemes for faster and efficient generalization of contextual information embedded in the feature map through feature recalibration and enhancement operations. Outstanding performances have been achieved in all three-tasks through extensive experimentation on a large publicly available dataset containing 1110 chest CT-volumes that signifies the effectiveness of the proposed scheme at the current stage of the pandemic.

No abstract

<p>Objective: The heart sound signals captured via a digital stethoscope are often distorted by environmental and physiological noise, altering their salient and critical properties. The problem is exacerbated in crowded low-resource hospital settings with high noise levels which degrades the diagnostic performance. In this study, we present a novel deep encoder-decoder based denoising architecture (LU-Net) to suppress ambient and internal lung sound noises. Methods: Training is done using a large benchmark PCG dataset mixed with physiological noise, i.e., breathing sounds. Two different noisy datasets were prepared for experimental evaluation by mixing unseen lung sounds and hospital ambient noises with the clean heart sound recordings. We also use the inherently noisy portion of the PASCAL heart sound dataset for evaluation. Results: The proposed framework showed effective suppression of background noises in both un?seen real-world data and synthetically generated noisy heart sound recordings, improving the signal-to-noise ratio (SNR) level by 5.575 dB on an average using only 1.32 M parameters. The proposed model outperforms the current state-of-the-art U-Net model with an average SNR improvement of 5.613 dB and 5.537 dB in the presence of lung sound and unseen hospital noise, respectively. LU-Net also outperformed the state-of-the-art Fully Convolutional Network (FCN) by 1.750 dB and 1.748 dB for lung sound and unseen hospital noise conditions, respectively. In addition, the proposed denoising method model improves classification accuracy by 38.93% in the noisy portion of the PASCAL heart sound dataset. Conclusion: The results presented in the paper indicate that our proposed architecture demonstrated a robust denoising performance on different datasets with diverse levels and characteristics of noise. Significance: The proposed deep learning-based PCG denoising approach is a pioneering study that can significantly improve the accuracy of computer-aided auscultation systems for detecting cardiac diseases in noisy, low-resource hospitals and underserved communities. </p>